Applied Clinical Trials-10-01-2006

To realize the goal of the directive, member states need to collaborate and make improvements.

Instructions for evaluating adverse event data and guidelines for taking the proper course of action

Regulatory submission solution addresses the needs of smaller biotech and pharma companies

Phase I package adds formulary accountability, recruitment, lab, and EDC features

There are a number of factors potential subjects need to consider when deciding whether to participate in a clinical trial, including an often overlooked matter that this month's authors examine: taxes.

System enables IRB members to review ?s in near real-time from anywhere in the world

Confusion over policies governing prisoners points to the need for clear, uniform safeguards for all research.

As more companies adopt eClinical technologies, data managers must redefine and update their role.

The importance of human subject protection, clear communication, and community spirit are among the issues emerging from the tragedy.

An insightful review of Remedica's 2005 Clinical Trials: A Practical Guide to Design, Analysis, and Reporting

The group's latest ODM release strengthens global reach and lets researchers define conditions in eCRFs.

Practical guidance for effectively integrating PDAs and other handheld devices into CTs

A new report from the European Union grades member states on their orphan drug incentives.